The mitochondrial DNA 9-bp deletion polymorphism is a risk factor for hepatocellular carcinoma in the chinese population

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 5, 2012, Pages 330-334

  Jin, Yiqi ^a   Yu, Qiang ^a   Zhou, Dayong ^a   Chen, Lei ^a   Huang, Xianchen ^a   Xu, Guoxiong ^a   Huang, Jian ^a   Gao, Xueren ^b   Gao, Yuzhen ^b   Shen, Liming ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MITOCHONDRIAL DNA; REPETITIVE DNA;

ADULT; ARTICLE; BINDING SITE; CANCER RISK; CASE CONTROL STUDY; CHI SQUARE TEST; CHINESE; CHROMOSOME DELETION; CHROMOSOME DELETION 9 BP; CONTROLLED STUDY; DNA FRAGMENTATION; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; RNA BINDING;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DNA, MITOCHONDRIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; POLYMORPHISM, GENETIC; RISK FACTORS; SEQUENCE DELETION;

EID: 84861507250     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0208     Document Type: Article

References (30)

1. Allen RC, Graves G, Budowle B (1989) Polymerase chain reaction amplification products separated on rehydratable polyacrylamide gels and stained with silver. Biotechniques 7:736-744.
2. Anderson S, Bankier AT, Barrell BG, et al. (1981) Sequence and organization of the human mitochondrial genome. Nature 290:457-465.
3. Barrey E, Saint-Auret G, Bonnamy B, et al. (2011) Pre-microRNA and mature microRNA in human mitochondria. PLoS One 6:e20220.
4. Basso D, Navaglia F, Fogar P, et al. (2007) DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis. Clin Chim Acta 381:50-55.
5. Bianchi NO, Bianchi MS, Richard SM (2001) Mitochondrial genome instability in human cancers. Mutat Res 488:9-23.
6. Burchard J, Zhang C, Liu AM, et al. (2010) microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol 6:402.
7. Chen CJ, Yu MW, Liaw YF (1997) Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 12:S294-S308.
8. Chen K, Song F, Calin GA, et al. (2008) Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis. 29:1306-1311.
9. Chen S, He Y, Ding J, et al. (2010) An insertion/deletion polymorphism in the 3¢ untranslated region of beta-transducin repeat-containing protein (betaTrCP) is associated with susceptibility for hepatocellular carcinoma in Chinese. Biochem Biophys Res Commun 391:552-556.
10. Cuezva JM, Krajewska M, de Heredia ML, et al. (2002) The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res 62:6674-6681.
11. Gao Y, He Y, Ding J, et al. (2009) An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3¢ untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis 30:2064-2069.
12. Ha HL, Shin HJ, Feitelson MA, et al. (2010) Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol 16:6035-6043.
13. He Y, Ni J, Chen S, et al. (2010) The vascular endothelial growth factor-2549 insertion/deletion polymorphism is not associated with susceptibility to hepatocellular carcinoma in Chinese. DNA Cell Biol 29:393-396.
14. Hoek JB, Cahill A, Pastorino JG (2002) Alcohol and mitochondria: a dysfunctional relationship. Gastroenterology 122:2049-2063.
15. John B, Enright AJ, Aravin A, et al. (2004) Human MicroRNA targets. PLoS Biol 2:e363.
16. Komandur S, Venkatasubramanian S, Alluri RV, et al. (2011) Mitochondrial insertion-deletion polymorphism: role in disease pathology. Genet Test Mol Biomarkers 15:361-364.
17. Krishnan KJ, Turnbull DM (2010) Mitochondrial DNA and genetic disease. Essays Biochem 47:139-151.
18. Lawless MW, O'Byrne KJ, Gray SG (2010) Targeting oxidative stress in cancer. Expert Opin Ther Targets 14:1225-1245.
19. Moradpour D, Blum HE (2005) Pathogenesis of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 17:477-483.
20. Nahon P, Sutton A, Pessayre D, et al. (2005) Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death. Clin Gastroenterol Hepatol 3:292-298.
21. Pillai, R.S. (2005) MicroRNA function: multiple mechanisms for a tiny RNA? RNA 12:1753-1761.
22. Shen L, Fang H, Chen T, et al. (2010) Evaluating mitochondrial DNA in cancer occurrence and development. Ann NY Acad Sci 1201:26-33.
23. Soodyall H, Vigilant L, Hill AV, et al. (1996) mtDNA controlregion sequence variation suggests multiple independent origins of an "Asian-specific" 9-bp deletion in sub-Saharan Africans. Am J Hum Genet 58:595-608.
24. Walsh PS, Metzger DA, Higuchi R (1991) Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 10:506-513.
25. Wang XW, Hussain SP, Huo TI, et al. (2002) Molecular pathogenesis of human hepatocellular carcinoma. Toxicology 181-182:43-47.
26. Wang Y, Jia J (2011) Control of hepatitis B in China: prevention and treatment. Expert Rev Anti Infect Ther 9:21-25.
27. Wrischnik LA, Higuchi RG, Stoneking M, et al. (1987) Length mutations in human mitochondrial DNA: direct sequencing of enzymatically amplified DNA. Nucleic Acids Res 15:529-542.
28. Yao YG, Watkins WS, Zhang YP (2000) Evolutionary history of the mtDNA 9-bp deletion in Chinese populations and its relevance to the peopling of east and southeast Asia. Hum Genet 107:504-512.
29. Yin PH, Lee HC, Chau GY, et al. (2004) Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br J Cancer 90:2390-2396.
30. Zhuo G, Feng G, Leng J, et al. (2010) A 9-bp deletion homoplasmy in women with polycystic ovary syndrome revealed by mitochondrial genome-mutation screen. Biochem Genet 48:157-163.